半岛bd体育手机客户端 说明
一般描述
Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.
应用
Ritonavir may be used as a pharmaceutical primary standard for the quantification of the analyte in pharmaceutical formulations using chromatography techniques.
包装
Unit quantity: 80 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
注意
Please find SDS provided by EDQM here..
其他说明
Sales restrictions may apply.
基本信息
| 经验(实验)分子式 | C37H48N6O5S2 |
| 分子量 | 720.94 |
| NACRES | NA.24 |
半岛bd体育手机客户端 性质
| 生物来源 | synthetic |
| 等级 | pharmaceutical primary standard |
| agency | EP |
| 包装 | pkg of 80 mg |
| manufacturer/tradename | EDQM |
| 储存条件 | protect from light |
| 溶解性 | ethanol: soluble methanol: soluble |
| application(s) | pharmaceutical (small molecule) |
| 格式 | neat |
| 运输 | ambient |
| 储存温度 | 2-8℃ |
| InChI | 1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 |
| InChI key | NCDNCNXCDXHOMX-XGKFQTDJSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 + H312 + H332 |
| 预防措施声明 | P261 - P280 - P301 + P312 + P330 |
| 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral |
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
Sigma-Aldrich
m.cnreagent.com
